Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessHealthEquity, Inc. (NASDAQ:HQY) Stock Upgrade and Investigation Insights

HealthEquity, Inc. (NASDAQ:HQY) Stock Upgrade and Investigation Insights

Add to Favorite
Added to Favorite


Raymond James upgraded HealthEquity, Inc. (NASDAQ:HQY) to a “Strong Buy” despite ongoing fraud concerns.
Levi & Korsinsky launched an investigation into HealthEquity for potential violations of federal securities laws following disappointing financial results.
The company’s stock price has experienced significant volatility, with a recent drop over 17% due to financial shortfalls attributed to “excess service expense” from cyber threats and fraud attacks.

HealthEquity, Inc. (NASDAQ:HQY) is a company that provides a range of services related to health savings accounts (HSAs) and other consumer-directed benefits. It operates in the healthcare sector, offering solutions that help individuals manage their healthcare expenses. HealthEquity competes with other companies in the financial services and healthcare sectors, such as UnitedHealth Group and Optum.

On March 25, 2025, Raymond James upgraded HealthEquity’s stock to a “Strong Buy,” despite ongoing fraud concerns. This upgrade came after the stock price settled at $90.19. Previously, the stock was rated as “Outperform,” as highlighted by Benzinga. This change in rating suggests confidence in the company’s potential, despite recent challenges.

Levi & Korsinsky has launched an investigation into HealthEquity for potential violations of federal securities laws. This follows the company’s announcement of its financial results for the fourth quarter and fiscal year ending January 31, 2025. HealthEquity reported earnings per share that did not meet analyst expectations and provided weak guidance for the upcoming fiscal year.

During an earnings call, HealthEquity’s officers explained the financial shortfall was due to “excess service expense” from increased cyber threats and fraud attacks. This news led to a significant drop in the stock price, falling over 17% on March 19, 2025. Despite this, the stock price currently stands at $90.19, reflecting a slight decrease of 0.14%.

The stock has fluctuated today between a low of $89.75 and a high of $93.64. Over the past year, HealthEquity’s stock has seen a high of $115.59 and a low of $65.01. The company’s market capitalization is approximately $7.8 billion, with a trading volume of 2,051,869 shares on the NASDAQ exchange.

Subscribe to get Latest News Updates

Latest News

You may like more
more

VolitionRx Limited’s Upcoming Earnings Report: A Deep Dive into Financial Health and Future Prospects

VolitionRx Limited (NYSEAMERICAN:VNRX) is set to release its quarterly...

Recent Market Movements: Analysis of Top Losers

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) saw a dramatic decrease of...

Ovintiv Inc. (NYSE: OVV) Set to Announce First Quarter 2025 Results

Ovintiv Inc. (NYSE:OVV) receives an upgrade from BMO Capital...